Neonatal Diabetes Mellitus: An Update on Diagnosis and Management

Neonatal Diabetes Mellitus: An Update on Diagnosis and Management

8^th World Conference on Pediatrics Child Health & Development
April 25, 2022 | Webinar

Mahmoud Metwaly Taha

Saudi German Hospital, Asser, KSA

Scientific Tracks Abstracts : Curr Pediatr Res

Abstract:

Neonatal diabetes mellitus (also termed congenital diabetes, or diabetes of infancy) is highly likely to be due to an underlying monogenic defect when it occurs under 6 months of age. Early recognition and urgent genetic testing are important for predicting the clinical course and raising awareness of possible additional features, and in many cases these are essential for guiding appropriate and cost-effective treatment. Additionally, early treatment of sulfonylurea-responsive types of neonatal diabetes may improve neurological outcomes. It is important to distinguish neonatal diabetes mellitus from other causes of hyperglycemia in the newborn. Other causes include infection, stress, inadequate pancreatic insulin production in the preterm infant, among others. Insulin-dependent hyperglycemia that persists longer than a week should raise suspicion for neonatal diabetes mellitus and prompt genetic testing.

Biography:

Dr. Mahmoud Metwaly Taha has a master degree in paediatrics and neonatology awarded from Zagazig University, Zigzag, Egypt. Currently working as senior neonatologist at Saudi German Hospital, Asser, and KSA.
• Full Name: Mahmoud Metwaly Taha
• Personal Email: Metawaly201390@gmail.com
• Mobile Number: +966 534341026
• Category: (Oral presentation)
• Date of Birth: 08/12/1979
• Postal Address: Saudi German Hospital Asser, Khamis Mushayt,
Saudia Arabia

PDF HTML